This experimental pill helped people lose about 16% of their body weight after about a year of treatment ...

Biotech picks highlight cystic fibrosis drug trials, rare-disease therapies and upcoming regulatory catalysts as clinical ...

Biotech stocks returned up to 36% in 2025, while longevity investing hit $8.5B in funding. Here’s the data individual investors should know.

Prasad contributed to an uncertain regulatory climate for gene therapy makers focused on rare conditions. Shares of many ...

The trial clearance for Shanghai-based Unixell is another step forward for the rapidly advancing Chinese biotech ecosystem, ...

Boris Nikolic’s career looked to be in tatters after his friendship with Jeffrey Epstein came to light in 2019. But he has ...

Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.

Sydney hedge fund Regal Partners Ltd. was dealt a fresh blow after Immutep Ltd., an Australian biotech company it backs, ...

Vinay Prasad, an official for the Food and Drug Administration, is reportedly stepping down, which is welcome news for ...

We're also trying to make sure we look back at some of the trades that are still alive so we can keep you posted. We wrote ...

Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.